Rothman Rb.Smoking Cessation in a Patient Being Treated with Fenfluramine Plus Phentermine for Simple Obesity.Journal of Clinical Psychiatry. 1996;57 (2): 92-93
3.
Toornvliet Ac,Pijl H,Hopman E.Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.International Journal of Obesity. 1996;20:917-920
4.
Coccaro Ef,Berman Me,Kavoussi Rj.Relationship of Prolactin Response to Dexfenfluramine to Behavioral and Questionnaire Assessments of Aggression in Personality-Disordered Men.Biological Psychiatry. 1996;40:157-164
5.
Toornvliet Ac,Pijl H,Hopman E.Predictors of weight loss during treatment with d-fenfluramine.Journal of Internal Medicine. 1997;241:401-406
6.
Budenholzer B.Appetite Suppressants for Obesity.Letter to the Editor in The Journal of Family Practice. 1997;Vol 44 (1): 19-20
7.
Barkin Rl.New Agent for Obesity Management.A letter in The Journal of Family Practice. 1996;Vol.43 (3): 224
8.
Swinburn Ba,Carmichael He,Wilson Mr.Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.International Journal of Obesity. 1996;20:1033-1040
9.
Khan M,Lum Ct,Rao V.Successful Appetite Suppression Therapy with Fenfluramine and Phentermine in the Obese Diabetic Transplant Patient.Transplantation Proceedings. 1995;Vol 27 (1): 975-976
10.
Naeije R,Maggiorini M,Delcroix M.Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs.American Journal of Respiratory and Critical Care Medicine.. 1996;154:1347-1350
11.
Voelkel Nf,Clarke Wr,Hegenbottam T.Obesity, Dexfenfluramine, and Pulmonary Hypertension. A Lesson Not Learned?.American Journal of Respiratory and Critical Care Medicine. 1997;Vol 155:786-788
12.
Havron Md.Diet Drugs and Pulmonary Hypertension, A review of Moride AL, Moride Y, Brenot F, et al: Appetite-suppressant drugs and risk of primary pulmonary hypertension.NEJM. 1996;335:609-16
13.
Cleare Aj.Phentermine, Psychosis, and Family History.A Letter in Journal of Clinical Psychopharmacology. 1996;Vol 16/No6:470-471
14.
Kokkinos J,Levine Sr.Possible Association of Ischemic Stroke with Phentermine.Stroke. 1993;24:310-313
15.
Fogelson Dl.Letter to the Editor.American Journal of Psychiatry. 1997;154 (3): 436-437
16.
Bostwick Jm,Brown Tm.A toxic reaction from combining fluoxetine and phentermine.In a letter to Journal of Clinical Psychopharmacol. 1996;Vol 16 (2): 189-190
17.
17.JohannesLStecklowS: Early Warning of Heart-Valve Problem That Felled Diet Pills Had Arisen Previously. U.S. Sellers Heard Reports From Belgium but Passed Only Some On to FDA. Redux Panel Was in the Dark. The Wall Street Journal, December 11, 1997.
18.
Goodman ,Gillman'S The Pharmacological Basis of Therapeutics. 9th EditionNew York: MacGraw Hill; 1995:
19.
Bray Ga.Treating Obesity with Drugs.Drug Ther. 1984;14:93-100
20.
O'Donnell Jt.Diets and Obesity Drug Treatment.Journal of Pharmacy Practice. 1996;Vol.IX (5): 330-341
21.
Weintraub M.Double-blind clinical trial in weight control: Use of fenfluramine and phentermine alone and in combination.Arch Intern Med. 1984;144:1143-1148
22.
Bray Ga.Nutrient Balance and Obesity: Approach to control of food intake in humans.Med Clin North Am. 1989;73:29-45
23.
Angel I.Anorectic activities of serotonin uptake inhibitors: Correlation with their potencies at inhibiting serotonin update in vivo and 3H-mazindol and binding in vitro.Life Sciences. 1988;43:651-658
O'Donnell JtChapter Revision Editor: 97 Drugs Used in Obesity in Drug Evaluation Annual. American Medical Association; 1992:2145-2160.
26.
Connolly Hm,Crary Jl,McGoon Md.Valvular Heart Disease Associated with Fenfluramine-Phentermine.The New England Journal of Medicine. 1997;337 (9): 581-588
27.
27.LemonickMd: The Mood Molecule. Time magazine, September 29, 1997: 74–82.
28.
Cohen H,Hoffman Rs,Howland Ma.Antidepressant Poisoning and Treatment: A Review and Case Illustration.Journal of Pharmacy Practice. 1997;Vol X (4): 251
